Molecular pathology of urothelial carcinoma

Antonio López-Beltrán(University of Córdoba), Liang Cheng(Brown University), Rodolfo Montironi(Marche Polytechnic University), Alessia Cimadamore(University of Udine)

Human Pathology

April 19, 2021

10.1016/j.humpath.2021.04.001

Cited by 58

Related Papers

Advances in diagnosis and treatment of bladder cancer

|BMJ|2024|442

Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine

|Modern Pathology|2017|404

Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer

|Cancers|2021|289

Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications

|Cells|2020|256

The World Health Organization 2016 classification of testicular non‐germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel

|Histopathology|2016|236